cerevel.com (CERE) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Nevropatologiyalar uchun dori vositalarini ishlab chiqish iqtisodiy sikllarga bog'liq emas; biroq, Cerevel Therapeutics (CERE) ilmiy yutuqlar borasida eng yirik sog'liqni saqlash gigantlari bilan shiddatli raqobatga duch kelmoqda. Aksiyalar narxlarining bozor tendentsiyasi 0.89 ko'rsatkichini namoyish etmoqda. Hozirda tadqiqot imkoniyatlari va laboratoriyalar maksimal darajada ishlatilmoqda, toza xonalardagi uskunalar esa klinik sinovlar uchun dori partiyalarini ishlab chiqarish maqsadida yangilanmoqda.
&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261031&filename=GURU_Markets_-_CERE_-_Cerevel-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "CERE - Cerevel Therapeutics, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 10.08.2024 oraligʻida | 👁️GURU.Markets👁️")
Cerevel Therapeutics (CERE) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Cerevel Therapeutics|CERE - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati cerevel.com|CERE - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Cerevel Therapeutics, Inc.|CERE - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Cerevel Therapeutics|Shoshilinch likvidlik cerevel.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:CERE (Cerevel Therapeutics Inc)
Neuroterapevtika bo'yicha tadqiqot va ishlanmalar (R&D) xarajatlari juda yuqori bo'lgan Cerevel Therapeutics (CERE) uchun GURU.Markets platformasidagi uzoq muddatli qarzdorlikning kapitalga nisbati moliyaviy barqarorlik ko'rsatkichi bo'lib xizmat qiladi. Ushbu metrika bir yildan ortiq muddatga ega majburiyatlarni emitentning kapitali bilan solishtiradi. U operatsion daromadlar mavjud bo'lmagan holatda kompaniyaning tashqi qarzlariga bo'lgan bog'liqligini o'lchaydi. Ushbu nisbatning oshishi kredit riskining ortganidan dalolat beradi. Biznesni kengaytirish chegaralarini tushunish uchun investorlar ushbu balansni baholashlari zarur.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati harmonybiosciences.com (HRMY)|Uzoq muddatli qarzning kapitalga nisbati BHVN|AMLX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|Uzoq muddatli qarzning kapitalga koeffitsiyenti PRAX|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ceribell.com|PRTA (Prothena Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ALEC (Alector) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ANNX (Annexon Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Omeros Corp. OMER|Uzoq muddatli qarzning o'z kapitaliga nisbati Neurogene Inc. (NGNE)|Uzoq muddatli qarzning o'z kapitaliga nisbati ACIU (acimmune.com)|Voyager Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti NMRA|SCLX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Tevogen Bio Inc. - Uzoq muddatli kreditlarning kapitalga nisbati|ACOG: Uzoq muddatli qarzning kapitalga nisbati|cogrx.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|IKT (Inhibikase Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Cassava Sciences Inc SAVA|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc. (ASRT)|COYA (coyatherapeutics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|Uzoq muddatli qarzning kapitalga nisbati Ovid Therapeutics Inc OVID|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati CRVO|ATHE: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Clene (CLNN)|Uzoq muddatli qarzning o'z kapitaliga nisbati PEPG|Uzoq muddatli qarzning kapitalga nisbati jupiterneurosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati RLMD (Relmada Therapeutics, Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati ANVS|Uzoq muddatli qarzning kapitalga nisbati GRCE (Grace Therapeutics)|Uzoq muddatli qarzdorlikning kapitalga nisbati Firefly Neuro (AIFF)|ANEW Medical, Inc. - Uzoq muddatli qarzning kapitalga nisbati|NeuroSense Therapeutics (NRSN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Uzoq muddatli qarzning o'z kapitaliga nisbati|MTVA - Uzoq muddatli qarzdorlikning kapitalga nisbati|NRXS (NeurAxis, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies Inc. (HSDT)|Uzoq muddatli qarzning kapitalga nisbati PASG|NEUP - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Minerva Neurosciences, Inc. NERV|Uzoq muddatli qarzning kapitalga koeffitsiyenti ATHA|Addex Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alzamend Neuro, Inc.|cyclerion.com (CYCN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi PTIX|KTTA (Pasithea Therapeutics Corp) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Cortigent Medical CRGT|Uzoq muddatli qarzning o'z kapitaliga nisbati ATXI (Avenue Therapeutics, Inc)|Uzoq muddatli qarzning kapitalga nisbati BrainStorm Cell Therapeutics Inc. (BCLI)|Uzoq muddatli qarzning o'z kapitaliga nisbati Cara Therapeutics, Inc. CARA|Uzoq muddatli qarzning kapitalga koeffitsiyenti CHRO|ELYM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Intra-Cellular Therapies|LBPH: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Marinus Pharma|NKGN (NKGen Biotech, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati neurobopharma.com NRBO|Uzoq muddatli qarzning o'z kapitaliga nisbati Sage Therapeutics (SAGE)|SNPX (Synaptogenix Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati TRVN (Trevena, Inc)|Vigil Neuroscience Inc. (VIGL) - Uzoq muddatli majburiyatlarning kapitalga nisbati|WENA: Uzoq muddatli qarzning o'z kapitaliga nisbati